Screening Research Study Open to Participants in Western Pennsylvania

A trial evaluating screening ultrasound after tomosynthesis (3D mammography) is

ongoing at the University of Pittsburgh School of Medicine/UPMC. Participants

must be between 40-75 years of age, have heterogeneously dense or extremely

dense breasts, have no symptoms of breast cancer, and no breast implants. The

study is funded by the National Cancer Institute and the Pennsylvania Breast

Cancer Coalition and will recruit 6200 women. Participants will receive

screening ultrasound each year for three years as part of the study provided

3D mammography is included as part of their usual breast screening.

For women interested in participating, please contact Dr. Wendie Berg

through her research coordinator Nicole Lettiere

at lettieren@mail.magee.edu.